Pharmacokinetic Study of Ravulizumab Administered Subcutaneously With Recombinant Human Hyaluronidase PH20 (rHuPH20) in Healthy Adult Volunteers
Clinical trial NCT05396742 · COMPLETED
Trial details
- NCT number
- NCT05396742
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-09
- Primary completion
- 2019-05-21
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.